Obi Greenman
Patrimonio netto: 15 M $ in data 30/06/2026
Patrimonio netto: 15 M $ in data 30/06/2026
William Mariner Greenman is Executive Chairman at Cerus Corp.
since 2026.
Former roles include Independent Director at Aduro BioTech, Inc., Independent Director at Chinook Therapeutics, Inc. from 2010 to 2023, and Senior Vice President-Biotech Division at Baxter International, Inc. in 1995.
Education includes undergraduate studies at Stanford University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CERUS CORPORATION 2,52% | 30/06/2026 | 5.053.036 ( 2,52% ) | 15 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CERUS CORPORATION | Presidente | 16/03/2026 |
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/08/2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale